Usted buscó: imunomoduliacija (Lituano - Inglés)

imunomoduliacija
immunomodulation

-netiesiogin ir tiesiogin imunomoduliacija
8-indirect and direct immunomodulation

vaikai, sergantys aids imunomoduliacija:
0.4 0.2 0.20.2­ 0.8 g/kg bw -thereafter: ­ 0.8 g/kg bw ­ 0.4 g/kg bw

toks gydymas vadinamas imunomoduliacija (imuniniu reguliavimu).
this type of treatment is called ‘ immunomodulation’ (immune adjustment).

imunomoduliacija suaugusiesiems, vaikams ir paaugliams (0–18 metų):
immunomodulation in adults, and children and adolescents (0-18 years) in:

­ vaikams, sergantiems aids imunomoduliacija ­ idiopatin trombocitopenin purpura
0.8­1 g/kg bw or 0.4 g/kg bw/d 0.4 g/kg bw/d 1.6­2 g/kg bw

sios rsies gydymas vadinamas imunomoduliacija (imuniteto koregavimu) .
this type of treatment is called immunomodulation (immune adjustment) .

sios ligos gydomos imunomoduliacija (imunins sistemos veiklos reguliavimu) .
this type of treatment is called ` immunomodulation'( immune adjustment) .

pakaitin terapija esant antriniam imuniteto nepakankamumuivaikai, sergantys aids imunomoduliacija:
0.4 ­ 0.8 g/kg bw -thereafter:0.2 ­ 0.8 g/kg bw0.2 ­ 0.4 g/kg bw0.2 ­ 0.4 g/kg bwevery 2 ­ 4 weeks to obtain igg minimum (trough) level of at least 4 ­ 6 g/levery 3 ­ 4 weeks to obtain igg trough level of at least 4 ­ 6 g/l

toks gydymas vadinamas imunomoduliacija (imuniniu reguliavimu). • pacientams, kuriems buvo persodinti kaulų čiulpai.
this type of treatment is called ‘ immunomodulation’ (immune adjustment). • patients who have had a bone marrow transplant.

Šios ligos gydomos imunomoduliacija (imuninės sistemos veiklos reguliavimu). • pacientams, kuriems buvo persodinti kaulų čiulpai.
this type of treatment is called ‘ immunomodulation’ (immune adjustment). • patients who have had a bone marrow transplant.

suaugusiesiems, vaikams ir paaugliams (2–18 metų), kuriems yra tam tikrų autoimuninių sutrikimų gydyti (imunomoduliacija).
treatment of adults, children and adolescents (2-18 years) with certain autoimmune disorders (immunomodulation).

zmonms skirt vaist komitetas (chmp) nusprend, kad zmoni, kuriems reikalinga pakaitin terapija, imunomoduliacija arba kaul ciulp transplantacija, gydymas kiovig gali bti kliniskai naudingas.
the committee for medicinal products for human use (chmp) decided that for patients who require replacement therapy, immunomodulation, or bone marrow transplantation, treatment with kiovig might provide clinical benefits.

imunomoduliacijai
immunomodulation